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Background: Sample-size calculations are critical to ensure that randomised control trials return robust and reliable results. The 
estimated treatment effects used in these calculations is often significantly different from the actual treatment effect and can 
dramatically impact trial validity.
Methods: This study examined sample-size calculations in randomised controlled trials designed to show superiority between 
two-arm parallel groups with a single primary outcome that were published in the top five anaesthetic journals for 2014 (as per 
Thomson Reuters impact factors). In particular, it sought to determine treatment effect estimations used in a priori sample-size 
calculations and compare them with actual treatment effects.
Results: A PubMed search identified 209 possible articles; 52 were drawn for full text review; and 28 were included in the final 
analysis. The relative difference between expected and actual event rates was greater than 20% in 80% of trials and greater than 
50% in 44% of trials.
Conclusions: Unrealistic assumptions of treatment effects in randomised controlled trials published in anaesthesia journals 
are common. Trial sample sizes should be calculated thoughtfully and realistically and should be fully reported in both trial 
protocols and publications. Researchers should be aware of the opportunity cost as well as the possible dangers to patients 
when unrealistic assumptions are made. Where possible researchers should collaborate to achieve meaningful trial sample sizes 
to ensure robust clinical findings.
Keywords: anaesthesia, clinical trial, power calculations, sample size, treatment effect, type II error
Introduction
Sample-size calculations are critical to ensure that randomised 
control trials return robust and reliable results. According to the 
CONSORT statement for the reporting of parallel-group 
randomised trials, these calculations should be reported and 
justified in the methods section.1 Sample-size calculations 
establish the patient numbers required to detect clinically 
relevant differences between interventions. Where trials are 
underpowered they run the risk of failing to identify a true 
difference between groups, and increase the likelihood of false-
positive trials—particularly when the null hypothesis is true.2 In 
contradistinction, excessively large sample sizes run the risk of 
unnecessarily exposing trial subjects to risk of a new intervention.3
The primary parameters used in calculating samples sizes are: (1) 
the threshold chosen for the type I error (also call the level of 
significance or the p-value—commonly set at 5%); (2) the study 
power (commonly set at 80% or 90%); (3) the assumed event rate 
in the control group, together with some assumed standard 
deviation; and (4) the expected treatment effect. Assumed event 
rate and its standard deviation are commonly based on 
previously reported results, while expected treatment effect 
should be based on what a clinically meaningful treatment effect 
would be considering the clinical study environment. These 
assumptions are often significantly different from actual trial 
findings and can dramatically impact the intended power of a 
trial.4
In this study we aimed to examine sample-size calculations in 
randomised controlled trials designed to show superiority 
between two-arm parallel groups with a single primary outcome 
that were published in the top five anaesthetic journals for 2014 
(as per Thomson Reuters impact factors). In particular, we sought 
to determine treatment effect estimations used in a priori 
sample-size calculations and compare them with the actual 
treatment effects identified by the trial.
Methodology
We systematically reviewed PubMed using the search terms 
‘randomized controlled trials’ and ‘randomised controlled trials’ 
to identify all 2014 clinical randomised controlled trials published 
in the five anaesthetic journals with the highest impact factor as 
reported by Thomson Reuters. Pain-specific journals were 
excluded. MN screened titles and abstracts to identify candidate 
articles. Articles were excluded if they were not randomised, 
were cluster trials, included a factorial design, were non-
inferiority trials, were pilot trials, made use of more than two trial 
arms, or reported more than one primary outcome. Articles were 
selected for full text review if either screener deemed them 
possibly eligible. Chance corrected inter-observer agreement for 
trial eligibility was tested using the kappa statistic.
A full text review of all candidate articles was conducted to 
identify eligible trials. From these eligible trials we systematically 
extracted the following data using a standardised data-collection 
sheet: author, year of publication, journal, p-value, power, 
expected control event rate, expected treatment effect, required 
sample size, actual number of recruited participants, actual 
control event rate, actual treatment effect, and intention-to-treat 
analysis. Full text screening and data extraction was conducted 
in duplicate by two teams, MN, SK and TM, BM, with the final data 
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Methodology
We systematically reviewed PubMed using the search terms 
‘randomized controlled trials’ and ‘randomised controlled trials’ 
to identify all 2014 clinical randomised controlled trials published 
in the five anaesthetic journals with the highest impact factor as 
reported by Thomson Reuters. Pain-specific journals were 
excluded. MN screened titles and abstracts to identify candidate 
articles. Articles were excluded if they were not randomised, 
were cluster trials, included a factorial design, were non-
inferiority trials, were pilot trials, made use of more than two trial 
arms, or reported more than one primary outcome. Articles were 
selected for full text review if either screener deemed them 
possibly eligible. Chance corrected inter-observer agreement for 
trial eligibility was tested using the kappa statistic.
A full text review of all candidate articles was conducted to 
identify eligible trials. From these eligible trials we systematically 
extracted the following data using a standardised data-collection 
sheet: author, year of publication, journal, p-value, power, 
expected control event rate, expected treatment effect, required 
sample size, actual number of recruited participants, actual 
control event rate, actual treatment effect, and intention-to-treat 
analysis. Full text screening and data extraction was conducted 
in duplicate by two teams, MN, SK and TM, BM, with the final data 
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being checked by RR. As no meta-analysis of study data was 
planned we did not assess trial quality or risk of bias.
For each trial the following were reported: sample-size 
calculation, power, alpha, two-sided testing assumption, 
calculated sample size, number of patients randomised, number 
of patients analysed, significance of trial findings, expected 
treatment effect, actual treatment effect, and the percentage 
relative difference between the estimated and actual event rates 
(estimated event rate minus actual event rate divided by 
estimated event rate). Where required, expected treatment 
effects reported in trial measurement units were converted to a 
percentage to facilitate comparison.
Results
In 2014 the five anaesthetic journals with the highest impact 
factor for 2014 were Anesthesiology, Anesthesia and Analgesia, 
British Journal of Anaesthesia, Anaesthesia, and the Canadian 
Journal of Anesthesia. The PubMed search identified 209 possible 
articles from which 52 were drawn for full paper review. Chance 
corrected inter-observer agreement for trial eligibility was 
excellent (kappa = 0.82). Twenty-four trials were subsequently 
excluded for the following reasons: Not randomized (2),5,6 pilot 
trial (4),7–10 cross-over trial (2),11,12 factorial (2),13,14 multiple 
outcomes (5),15–19 secondary analysis (4),20–23 using dynamic 
sample size calculations (1),24 non-inferiority trial (2),25,26 and trial 
stopped early (2).27,28 Trial selection process is shown in 0 1, 
sample-size calculation details of the 28 included trials are 
reported in Table 1, and a comparison of expected and actual 
treatment effects are provided in Table 2.
All trials reported a sample size calculation. Two trials explicitly 
used one-sided assumptions when calculating the sample 
size36,54 while 13 trials did not explicitly report two-sided 
assumptions.33,35,37–39,42,46,48–53 All studies (for brevity hereafter 
name of first author only given) made use of an alpha of 0.05 and 
power of 80%, except for Caperellei, Cheung and Yates, who used 
90% power,30,31,54 and Liu who used 95% power and an alpha of 
0.001.43 Three trials did not achieved their planned sample 
size.39,48,51 Of note Saporito,46 Stein,49 and Cheung31 recruited 
between 50% and 100% more patients than required by their 
sample-size calculations. In addition, Saporito et al. powered 
their trial to show superiority between two interventions but 
conducted a non-inferiority trial.46
All trials except for Ju reported an expected treatment effect; in 
addition Ju did not use the outcome that the trial was powered 
on as the primary reported trial outcome.38 Justification for the 
expected treatment effect was provided for 16 trials (57%): 12 
from prior trials; 2 from pilot studies; 1 from observational data; 1 
from clinical relevance. For the remaining 12 trials (43%) no 
justification was provided.
The relative difference between the expected and actual event 
rates was greater than 20% in 80% of trials and greater than 50% 
in 44% of trials. In six trials the actual treatment effect was in the 
opposite direction to that expected,34,37,40,41,51,4 of which one trial 
had explicitly made use of a one-sided power calculation.54 
Eleven trials were designed using expected treatment effects 
greater than 20% of actual reported non-significant 
results,30,32,34,40,41,43,47,51,52,54,55 of which seven used expected 
treatment results greater than 50% of actual reported.30,41,43,47,51,54,55
Discussion
Sample-size calculations form the basis of robust evidence-
based medicine. Randomised controlled trials need to be of high 
quality and so require, among other things, a published a priori 
sample size and power calculation.57 This allows the trial to be 
reproduced and explains the researchers’ underlying 
assumptions in designing the trial. An appropriate sample size is 
determined by the following design parameters: minimum 
expected difference (also known as the effect size), estimated 
measurement variability, desired statistical power, significance 
criterion (p-value), and whether a one- or two-tailed statistical 
analysis is planned.58 Factors resulting in the need for a large 
sample size are: the desire for a highly powered study, small 
treatment effect, smaller p-values, the desire for narrower 
confidence intervals, two-tailed design of the study and 
increasing variability/standard difference.
Several studies in the recent past have examined power and 
sample-size calculations and have noted that a large percentage 
of randomised controlled trials are either underpowered or have 
no record of an a priori sample-size calculation. Further, many 
trials were found to have low statistical power thereby increasing 
the probability of a type II error.2,57 Christley et al., in a review of 
the surgical literature, noted that of 127 randomised controlled 
trials only half were sufficiently powered to detect large 
differences between treatment groups.2 These underpowered 
studies may even have affected meta-analyses where low-
powered studies with significant results have been included, 
especially when they have negative results. Muncer et al. note 
that by ignoring power the single-study researcher makes it 
Figure 1: Trial selection process.
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difficult to get negative results published and therefore affects 
meta-analysis through publication bias.59
In this analysis more than 80% of trials overestimated the 
treatment effect by more than 20% and 44% of trials by more 
than 50%. Similarly, in an analysis of internal medicine trials 
Charles et al. found significant discrepancies between expected 
and observed treatment effects.57 The reason for these findings is 
unclear. It may possibly be due to overzealous estimation of the 
estimated parameters with a desire to lower the required sample 
size. This is done by first choosing a convenient study period (e.g. 
six months) or attainable study sample size (e.g. 100/200/300 etc. 
participants) and then plugging in a treatment effect that 
provides the desired sample size. While it is not formally 
necessary that the actual treatment effect should resemble the 
estimated treatment effect, studies designed using unrealistic 
treatment effects expose patients to trial risks and waste 
resources without the benefit of achieving a meaningful 
result.60,61
In this analysis 11 trials with estimated treatment effects greater 
than 20% of actual reported non-significant results, of which 
seven used expected treatment results greater than 50% of 
actual.
One of these trials assumed a 66% reduction in the composite of 
death and prolonged ICU stay but reported a 13% increase in the 
primary outcome,41 while a second assumed a 60% decrease in 
the incidence of gastrointestinal morbidity but reported a 7% 
increase.54 We would argue that the treatment effects assumed in 
many of these trials are unrealistic, especially considering the 
nature of some of the outcomes being studied. Many of these 
trials are therefore practically underpowered and would likely 
necessitate a second larger trial. It is worth noting that Yates et 
al.54 made use of one-sided assumptions when calculating their 
sample size, but found a treatment effect in the opposite 
direction than expected. This highlights the danger of using one-
sided sample-size assumptions in clinical research.
Trial designers do not only err by making sample sizes too small. 
In this analysis Saporito and Cheung doubled their sample 
size,31,46 and Stein recruited 68% more patients than required 
without providing a clear motivation for doing so.49 While it is 
appropriate to increase sample size to account for patient 
dropout these considerations should be made explicit in the trial 
protocol. Recruiting excessive patients without a reasoned 
rational unnecessarily exposes them to possible harm.
Table 1: Sample-size calculation characteristics of included trials
Note: NR—not reported; NS—not specified.
Author Sample size calculation Power Alpha Two-sided? Sample size
Calculated Randomised Analysed Sample size achieved?
Arab29 Yes 80% 5% Yes 96 96 96 Yes
Cappelleri30 Yes 90% 5% Yes 76 90 83 Yes
Cheung31 Yes 90% 5% Yes 50 100 96 Yes
Cho32 Yes 80% 5% Yes 78 78 78 Yes
Ferrando33 Yes 80% 5% NS 30 30 30 Yes
Kuruba34 Yes 80% 5% Yes 54 54 51 Yes
Horn35 Yes 80% 5% NS 40 40 40 Yes
Hwang36 Yes 80% 5% One-sided 62 68 66 Yes
Ilyas37 Yes 80% 5% NS 128 128 128 Yes
Ju38 Yes 80% 5% NS 84 100 84 Yes
Kim39 Yes 80% 5% NS 166 184 181 Yes
Kim40 Yes 80% 5% Yes 46 55 53 No
Landoni41 Yes 80% 5% Yes 186 200 200 Yes
Lim42 Yes 80% 5% NS 56 62 60 Yes
Liu43 Yes 95% 1% Yes 288 680 601 Yes
Murphy44 Yes 80% 5% Yes 62 70 70 Yes
Paul45 Yes NR 5% NR NR 40 40 NA
Saporito46 Yes 80% 5% NS 60 122 120 Yes
Sharma47 Yes 80% 5% Yes 400 400 302 Yes
Sng48 Yes 80% 5% NS 216 216 213 No
Stein49 Yes 80% 5% NS 86 116 109 Yes
Ueki50 Yes 80% 5% NS 34 42 37 Yes
van Loon51 Yes 80% 5% NS 440 427 415 No
Westergaard52 No NR NR NS 52 60 59 Yes
Yamamoto53 Yes 80% 5% NS 78 90 86 Yes
Yates54 Yes 90% 5% One-sided 202 206 202 Yes
Yoshida55 Yes 80% 5% Yes 44 60 54 Yes
Zhang56 Yes 80% 5% Yes 46 72 65 Yes
Sample-size determination and adherence in randomised controlled trials published in anaesthetic journals
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/ojaa 23
42 Southern African Journal of Anaesthesia and Analgesia 2018; 24(2):40–46
difficult to get negative results published and therefore affects 
meta-analysis through publication bias.59
In this analysis more than 80% of trials overestimated the 
treatment effect by more than 20% and 44% of trials by more 
than 50%. Similarly, in an analysis of internal medicine trials 
Charles et al. found significant discrepancies between expected 
and observed treatment effects.57 The reason for these findings is 
unclear. It may possibly be due to overzealous estimation of the 
estimated parameters with a desire to lower the required sample 
size. This is done by first choosing a convenient study period (e.g. 
six months) or attainable study sample size (e.g. 100/200/300 etc. 
participants) and then plugging in a treatment effect that 
provides the desired sample size. While it is not formally 
necessary that the actual treatment effect should resemble the 
estimated treatment effect, studies designed using unrealistic 
treatment effects expose patients to trial risks and waste 
resources without the benefit of achieving a meaningful 
result.60,61
In this analysis 11 trials with estimated treatment effects greater 
than 20% of actual reported non-significant results, of which 
seven used expected treatment results greater than 50% of 
actual.
One of these trials assumed a 66% reduction in the composite of 
death and prolonged ICU stay but reported a 13% increase in the 
primary outcome,41 while a second assumed a 60% decrease in 
the incidence of gastrointestinal morbidity but reported a 7% 
increase.54 We would argue that the treatment effects assumed in 
many of these trials are unrealistic, especially considering the 
nature of some of the outcomes being studied. Many of these 
trials are therefore practically underpowered and would likely 
necessitate a second larger trial. It is worth noting that Yates et 
al.54 made use of one-sided assumptions when calculating their 
sample size, but found a treatment effect in the opposite 
direction than expected. This highlights the danger of using one-
sided sample-size assumptions in clinical research.
Trial designers do not only err by making sample sizes too small. 
In this analysis Saporito and Cheung doubled their sample 
size,31,46 and Stein recruited 68% more patients than required 
without providing a clear motivation for doing so.49 While it is 
appropriate to increase sample size to account for patient 
dropout these considerations should be made explicit in the trial 
protocol. Recruiting excessive patients without a reasoned 
rational unnecessarily exposes them to possible harm.
Table 1: Sample-size calculation characteristics of included trials
Note: NR—not reported; NS—not specified.
Author Sample size calculation Power Alpha Two-sided? Sample size
Calculated Randomised Analysed Sample size achieved?
Arab29 Yes 80% 5% Yes 96 96 96 Yes
Cappelleri30 Yes 90% 5% Yes 76 90 83 Yes
Cheung31 Yes 90% 5% Yes 50 100 96 Yes
Cho32 Yes 80% 5% Yes 78 78 78 Yes
Ferrando33 Yes 80% 5% NS 30 30 30 Yes
Kuruba34 Yes 80% 5% Yes 54 54 51 Yes
Horn35 Yes 80% 5% NS 40 40 40 Yes
Hwang36 Yes 80% 5% One-sided 62 68 66 Yes
Ilyas37 Yes 80% 5% NS 128 128 128 Yes
Ju38 Yes 80% 5% NS 84 100 84 Yes
Kim39 Yes 80% 5% NS 166 184 181 Yes
Kim40 Yes 80% 5% Yes 46 55 53 No
Landoni41 Yes 80% 5% Yes 186 200 200 Yes
Lim42 Yes 80% 5% NS 56 62 60 Yes
Liu43 Yes 95% 1% Yes 288 680 601 Yes
Murphy44 Yes 80% 5% Yes 62 70 70 Yes
Paul45 Yes NR 5% NR NR 40 40 NA
Saporito46 Yes 80% 5% NS 60 122 120 Yes
Sharma47 Yes 80% 5% Yes 400 400 302 Yes
Sng48 Yes 80% 5% NS 216 216 213 No
Stein49 Yes 80% 5% NS 86 116 109 Yes
Ueki50 Yes 80% 5% NS 34 42 37 Yes
van Loon51 Yes 80% 5% NS 440 427 415 No
Westergaard52 No NR NR NS 52 60 59 Yes
Yamamoto53 Yes 80% 5% NS 78 90 86 Yes
Yates54 Yes 90% 5% One-sided 202 206 202 Yes
Yoshida55 Yes 80% 5% Yes 44 60 54 Yes
Zhang56 Yes 80% 5% Yes 46 72 65 Yes














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Southern African Journal of Anaesthesia and Analgesia 2018; 24(2)
The page number in the footer is not for bibliographic referencingwww.tandfonline.com/ojaa 24
44 Southern African Jour al of Anaesthesia and Analgesia 2018; 24(2):40–46
Anesthesia/Journal canadien d'anesthésie. 2014;61(11):995–1003. 
https://doi.org/10.1007/s12630-014-0226-6
10.  Bidd H, Dulai R, Edelman N, et al. The effect of intra-operative passive 
movement therapy on non-surgical site pain after breast reconstructive 
surgery: a preliminary study. Anaesthesia. 2014;69(8):872–7. 
https://doi.org/10.1111/anae.12729
11.  Bendtsen TF, Pedersen EM, Haroutounian S, et al. The suprasacral 
parallel shift vs lumbar plexus blockade with ultrasound guidance 
in healthy volunteers–a randomised controlled trial. Anaesthesia. 
2014;69(11):1227–40. https://doi.org/10.1111/anae.12753
12.  Hashimoto Y, Asai T, Arai T, et al. Effect of cricoid pressure on placement 
of the I-gel™: a randomised study. Anaesthesia. 2014;69(8): 878–82. 
https://doi.org/10.1111/anae.12731
13.  Lindholm EE, Aune E, Frøland G, et al. Analysis of transthoracic 
echocardiographic data in major vascular surgery from a prospective 
randomised trial comparing sevoflurane and fentanyl with propofol 
and remifentanil anaesthesia. Anaesthesia. 2014;69(6):558–72. 
https://doi.org/10.1111/anae.12604
14.  Sohn LE, Jagannathan N, Sequera-Ramos L, et al. A randomised 
comparison of free-handed vs air-Q assisted fibreoptic-guided tracheal 
intubation in children < 2 years of age. Anaesthesia. 2014;69(7):723–8. 
https://doi.org/10.1111/anae.2014.69.issue-7
15.  de Man FR, Erwteman M, van Groeningen D, et al. The effect of audible 
alarms on anaesthesiologists’ response times to adverse events in a 
simulated anaesthesia environment: a randomised trial. Anaesthesia. 
2014;69(6):598–603. https://doi.org/10.1111/anae.12640
16.  Adelborg K, Al-Mashhadi RH, Nielsen LH, et al. A randomised 
crossover comparison of manikin ventilation through Soft Seal(R), 
i-gel and AuraOnce supraglottic airway devices by surf lifeguards. 
Anaesthesia. 2014;69(4):343–7. https://doi.org/10.1111/anae.12545
17.  Yin J, Wang SL, Liu XB. The effects of general anaesthesia 
on memory in children: a comparison between propofol 
and sevoflurane. Anaesthesia. 2014;69(2):118–23. 
https://doi.org/10.1111/anae.2014.69.issue-2
18.  Englberger L, Dietrich W, Eberle B, et al. A novel blood-sparing 
agent in cardiac surgery? First in-patient experience with 
the synthetic serine protease inhibitor MDCO-2010: a phase 
II, randomized, double-blind, placebo-controlled study in 
patients undergoing coronary artery bypass grafting with 
cardiopulmonary bypass. Anesth Analg. 2014;119(1):16–25. 
https://doi.org/10.1213/ANE.0000000000000218
19.  Kancir AS, Pleckaitiene L, Hansen TB, et al. Lack of nephrotoxicity 
by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a 
randomized controlled trial. Anesthesiology. 2014;121(5):948–58. 
https://doi.org/10.1097/ALN.0000000000000413
20.  Brown CHt, Azman AS, Gottschalk A, et al. Sedation depth 
during spinal anesthesia and survival in elderly patients 
undergoing hip fracture repair. Anesth Analg. 2014;118(5):977–80. 
https://doi.org/10.1213/ANE.0000000000000157
21.  Meyhoff CS, Jorgensen LN, Wetterslev J, et al. Risk of new or recurrent 
cancer after a high perioperative inspiratory oxygen fraction 
during abdominal surgery. Br J Anaesth. 2014;113(Suppl 1):i74–81. 
https://doi.org/10.1093/bja/aeu110
22.  Singh PP, Lemanu DP, Taylor MH, et al. Association between 
preoperative glucocorticoids and long-term survival and cancer 
recurrence after colectomy: follow-up analysis of a previous 
randomized controlled trial. Br J Anaesth. 2014;113(Suppl 1):i68–73. 
https://doi.org/10.1093/bja/aet577
23.  Whitlock EL, Torres BA, Lin N, et al. Postoperative delirium in 
a substudy of cardiothoracic surgical patients in the BAG-
RECALL clinical trial. Anesth Analg. 2014;118(4):809–17. 
https://doi.org/10.1213/ANE.0000000000000028
24.  Mercier FJ, Diemunsch P, Ducloy-Bouthors AS, et al. 6% Hydroxyethyl 
starch (130/0.4) vs Ringer’s lactate preloading before spinal 
anaesthesia for Caesarean delivery: the randomized, double-
blind, multicentre CAESAR trial. Br J Anaesth. 2014;113(3):459–67. 
https://doi.org/10.1093/bja/aeu103
25.  Twersky RS, Goel V, Narayan P, et al. The risk of hypertension after 
preoperative discontinuation of angiotensin-converting enzyme 
inhibitors or angiotensin receptor antagonists in ambulatory and 
same-day admission patients. Anesth Analg. 2014;118(5):938–44. 
https://doi.org/10.1213/ANE.0000000000000076
Traditionally sample-size calculations are performed during the 
design phase of a trial and are rarely revisited. A trial excluded 
during full text review provides a different perspective on this 
approach. Mercier et al. initially assumed a 35% event rate in the 
baseline group with a 20% treatment effect.24 The authors 
planned a sample-size recalculation once 50% of patients had 
been randomised to ensure that adequate power was achieved—
the trial p-value was adjusted to correct for multiple testing. 
Adopting this model of trial design ensures that that the trial is 
adequately powered and provides reliable results.
Clinical medicine faces the challenge of dealing with a flood of 
inconclusive research and questions being asked of how we go 
about improving the reliability of our research.62,63 Locally, South 
African clinical trainees are producing a multitude of small 
underpowered studies in an attempt to fulfil regulator training 
requirements.64 To address these problems researchers should 
be aware of the opportunity cost as well as the possible dangers 
to patients when robust research methodology is not followed. 
Trial sample sizes should be calculated thoughtfully and 
realistically and should be fully reported in both trial protocols 
and publications. Where possible researchers should aim to 
collaborate so as to achieve meaningful trial sample sizes and so 
ensure robust clinical findings.
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